Journal article

Health Economic Evidence for Liquid- and Tissue-based Molecular Tests that Inform Decisions on Prostate Biopsies and Treatment of Localised Prostate Cancer: A Systematic Review

Koen Degeling, Amanda Pereira-Salgado, Niall M Corcoran, Paul C Boutros, Peter Kuhn, Maarten J IJzerman



Context: Several liquid- and tissue-based biomarker tests (LTBTs) are available to inform the need for prostate biopsies and treatment of localised prostate cancer (PCa) through risk stratification, but translation into routine practice requires evidence of their clinical utility and economic impact. Objective: To review and summarise the health economic evidence on the ability of LTBTs to inform decisions on prostate biopsies and treatment of localised PCa through risk stratification. Evidence acquisition: A systematic search was performed in the EMBASE, MEDLINE, Health Technology Assessment, and National Health Service Health Economic Evaluation databases. Eligible publications were those ..

View full abstract


Awarded by NCI Cancer Center support grant

Funding Acknowledgements

This work was part of the PRECEPT program funded by the Prostate Cancer Research Alliance, which is a joint initiative between the Movember Foundation and the Australian Government. Peter Kuhn is supported by NCI Cancer Center support grant P30 CA014089.